A5034923832- HIV, Drug Use, Sexual Risk
- Opioid Use Disorder Treatment
- HIV/AIDS Research and Interventions
- Hepatitis C virus research
- Substance Abuse Treatment and Outcomes
- Healthcare Systems and Practices
- Homelessness and Social Issues
- Sex work and related issues
- Alcohol Consumption and Health Effects
- Education, sociology, and vocational training
- Crime, Illicit Activities, and Governance
- Liver Disease Diagnosis and Treatment
- COVID-19 and Mental Health
- Cannabis and Cannabinoid Research
- Criminal Justice and Corrections Analysis
- COVID-19 epidemiological studies
- Misinformation and Its Impacts
- Mental Health and Patient Involvement
- Influenza Virus Research Studies
- Pharmacovigilance and Adverse Drug Reactions
- Liver physiology and pathology
- Hepatitis B Virus Studies
- Blood donation and transfusion practices
- Southeast Asian Sociopolitical Studies
- Psychedelics and Drug Studies
Centre National de la Recherche Scientifique
2015-2025
École des hautes études en sciences sociales
2018-2025
Inserm
2015-2025
British Columbia Centre on Substance Use
2021-2025
Center for Law and Social Policy
2020-2025
University at Buffalo, State University of New York
2024
Université de Sherbrooke
2024
Institut thématique Santé Publique
2024
Centre de Recherche Médecine, Sciences, Santé, Santé Mentale, Société
2010-2024
Santé Publique France
2019-2024
Highlights•Chronic HCV prevalence and treatment rates among PWID vary widely across Europe.•HCV scale-up is required in most sites to reduce transmission.•Increasing OST/NSP coverage enhances prevention benefit.Graphical abstractAbstractBackground & AimsPrevention of hepatitis C virus (HCV) transmission people who inject drugs (PWID) critical for eliminating Europe. We estimated the impact current scaled-up with without scaling up opioid substitution therapy (OST) needle syringe programmes...
Hepatitis C virus (HCV) seroprevalence remains high in people who inject drug (PWID) populations, often above 60%. Highly effective direct‐acting antiviral (DAA) regimens (90% efficacy) are becoming available for HCV treatment. This therapeutic revolution raises the possibility of eliminating from this population. However, this, an cascade care is required. In context DAA therapies, we used a dynamic individual‐based model including PWID social network to simulate impact improved testing,...
Epidemiology of HCV infection among drug users (DUs) has been widely studied. Prevalence and sociobehavioural data DUs are therefore available in most countries but no study taken into account the sampling weights one important aspect way life DUs, namely that they can use or more specialized services during period. In 2004–2005, we conducted a national seroepidemiologic survey based on random design using Generalised Weight Share Method (GWSM) blood testing. A cross-sectional multicenter...
Binary file ES_Abstracts_Final_ECDC.txt matches
Injection drug use remains a primary driver of HIV and HCV-related harms globally. However, there is gap in efforts to prevent individuals from transitioning into injecting. People who inject drugs (PWID) play key role the transition others injecting, while behavioral interventions have been developed address this phenomenon, socio-structural approaches remain unexplored. To that end, we hypothesize certain designed reduce injecting-related risk behaviors may also PWID expose introduce...
Although there is evidence describing how coping strategies can impact mental health outcomes and inequities among young adults, little known about different sub-groups of adults engage with positive the association challenges. Data were drawn from an online cross-sectional survey (July–December 2021) aged 18–30 years who reported experiencing COVID-19-related stress in Canada (n=2288) France (n=1891) during second year pandemic. Latent class analysis was used to identify classes similar...
Background: Opioid agonist therapies (OAT), including methadone and buprenorphine, are first-line care in national international guidelines, yet many countries, the United States, frequently fail to effectively engage retain people OAT. How OAT is delivered—including goals culture of care—matters patient engagement, treatment retention, health outcomes. France has among highest receipt lowest opioid-related morbidity mortality worldwide. This study explored French interprofessional...
An overall decrease in alcohol consumption has recently been observed among a growing segment of the youth population Western countries. Our study aimed to assess evolving trends rates current-, former- and never- drinkers 18-30-year-old French individuals between 2000 2021, compare their socio-economic characteristics, psychoactive substance use, health-related parameters. We used cross-sectional survey data from 2000, 2005, 2010, 2014, 2017 2021 editions Health Barometer, tested existence...
This paper focuses on the way drug users (DUs) play an active role in implementing public health policies by their involvement self-support groups, thus providing new forms of patients' expertise. Expertise this nature may seem paradoxical, that it confers qualities to populations whose practices are unlawful and identity is stigmatised. A qualitative method including semi directive interviews (57) ethnographic observations was used for research. thematic content analysis done from empirical...
Prisoners constitute a high-risk population, particularly for infectious diseases. The aim of this study was to estimate the level risk in prisons five different European countries by measuring what extent prison system adheres WHO/UNODC recommendations. Following methodology used previous French survey, postal/electronic questionnaire sent all Austria, Belgium, Denmark and Italy collect data on availability several recommended HIV-HCV prevention interventions HBV vaccination prisoners. A...
Abstract Aims The primary aim of this study was to evaluate the impact drug consumption rooms (DCRs) in France on injection equipment‐sharing, while secondary aims focused upon their access hepatitis C virus (HCV) testing and opioid agonist treatment (OAT). Design COhort identify Structural INdividual factors associated with USe (COSINUS cohort) a 12‐month longitudinal 665 people who inject drugs (PWID), conducted Bordeaux, Marseille, Paris Strasbourg. We used data from face‐to‐face...
Drug consumption rooms (DCRs) have the potential to a positive impact on opioid overdose crisis. DCRs could also potentially change political environment for public health because they can affect distribution of responsibility harm reduction between individual and society by collectivizing through welfare regimes. The methodology is based 2 case studies-1 in Copenhagen, Denmark, 1 Paris, France-about residents, people who inject drugs (PWID), politicians' experiences involving semidirective...
In France a harm-reduction policy was implemented in the late 1980s with aim of reducing prevalence HIV and hepatitis C virus (HCV) infection among drug users. The ANRS-Coquelicot survey designed to measure HCV users examine determinants at-risk behaviors. 2002, information collected from 166 recruited all types services specializing use intervention harm reduction Marseille, France. Self-reported serostatus compared results serological tests done on capillary blood filter paper....
Overpopulation, poor hygiene and disease prevention conditions in prisons are major structural determinants of increased infectious risk within prison settings but evidence-based national WHO guidelines provide clear indications on how to reduce this risk. We sought estimate the level by measuring French adhere guidelines.A nationwide survey targeting heads medical (all prisons) psychiatric (26 units was conducted using a postal questionnaire phone interview mainly focusing access...
Introduction The high prevalence of hepatitis C and the persistence HIV virus (HCV) risk practices in people who inject drugs (PWID) France underlines need for innovative prevention interventions. main objective this article is to describe design COSINUS cohort study outline issues it will explore evaluate impact drug consumption rooms (DCR) on PWID outcomes. Secondary objectives are assess how DCR (a) influence other drug-related practices, such as transition from intravenous less risky...
Drawing on ethnographies of a public health programme called ‘safer injection education’ (where people inject drugs under the supervision harm reduction providers), this article explores how materialities drug use (such as paraphernalia and space) intersect with habitual behaviours expectations. The compares diverse accounts who biomedical knowledge professionals to argue that experience different forms pleasure which challenge clinical understandings addiction driven by desire alleviate...
Abstract Background People who inject drugs (PWID) experience many health problems which result in a heavy economic and public burden. To tackle this issue, France opened two drug consumption rooms (DCRs) Paris Strasbourg 2016. This study assessed their long-term benefits, costs cost-effectiveness. Methods We developed model to simulate fictive cohorts for each city ( n =2,997 =2,971 Strasbourg) i) PWID attending DCR over the period 2016-2026, ii) no DCR. The accounted HIV HCV infections,...
After the collapse of Soviet Union at beginning 1990s, people who inject drugs spiked in Eastern Europe. Facing local repression and an array factors encouraging emigration, some users have migrated to France. This population now make up a third patient list harm reduction services Paris. article aims present original data on sociodemographic profiles these users, their migration trajectory, life conditions, evolution drug use practices since arriving Paris.Data were collected as part...
BackgroundPeople who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes.AimWe aimed to estimate the associations between a history of incarceration and prevalence HIV HCV infection among PWID in Europe.MethodsAggregate data from recruited drug services (excluding prison services) or elsewhere community were reported by 17 30 countries (16 per virus) collaborating European monitoring system (2006-2020; n = 52,368 HIV+/-; 47,268 HCV+/-)....